DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Filtration Market Size, Share & Trends Analysis Report 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.
The global pharmaceutical filtration market size is estimated to reach USD 21.96 billion by 2030, registering a CAGR of 8.03% from 2023 to 2030.
The market is expected to expand at a CAGR of 8.03% from 2023 to 2030.The growing biopharmaceutical industry provides the necessary impetus for market expansion. Additionally, the rampant growth and approvals by regulatory bodies in the field of biologics and biosimilar medicines have extrapolated the need for filtration at various stages of production.
For example, nearly ten large molecule drugs or biologics were approved by the U.S. FDA in 2021, which increased by 30% in the year 2022 as thirteen biologics were approved. Thereby, the increasing approvals will propel the market’s growth.
Various players involved in biopharmaceutical manufacturing are entering into collaborations or regional regulatory bodies are allowing for offshore manufacturing of large molecule drugs which provides a strong impetus to the market growth. For instance, in August 2022, Europe Medicines Agency provided Good Manufacturing Practice (GMP) certification to a CDMO, Charles River Laboratories of the U.S.
The following certification will now allow for offshore manufacturing of allogenic cell therapy products, thereby increasing the demand for pharmaceutical filtration products. Additionally, various market players are introducing filtration technology at both upstream and downstream levels of biopharmaceutical manufacturing, hence, proportionating the demand for pharmaceutical filter products.
For example, in November 2022, Alfa Laval launched a multipurpose membrane filtration system for upstream and downstream application levels for both food and pharmaceutical manufacturing.
Due to the onset of the pandemic, a surge in the development of vaccines and biologics led to a positive impact on pharmaceutical filtration products as biopharmaceutical manufacturing requiring the usage of vaccines necessitate filtration processes. Furthermore, the utilization of single-use filtration products provided immense traction to the market, as manufacturers and researchers had to avoid any chance of cross-contamination with the viral strains used.
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Merck KGaA.
- Eaton
- Graver Technologies
- Danaher
- 3M
- Parker Hannifin Corp.
- Amazon Filters Ltd.
- Sartorius AG
- Meissner Filtration Products, Inc.
Pharmaceutical Filtration Market Report Highlights
- By product, the membrane filter segment held the largest share of 26.08% in 2022. The product provides precise and uniform pore size distribution along with consistent purification capacity, ensuring pharmaceutical manufacturing standards
- By technique, microfiltration held the major share of 34.41% in 2022, due to the versatility to remove a wide range of impurities from biopharma products. Additionally, the technique removes impurities without impacting the biological activities of the medium
- By type, the sterile segment captured a dominant share of 55.79% in 2022 as it provides a critical manufacturing step in a plethora of pharmaceutical products. Additionally, the inclusion of automation in the process of sterile pharmaceutical filtration propels the segment
- The final product processing application segment accounted for the largest market share of 41.55% in 2022. It is primarily to ensure the safety and efficacy of the product by removing any form of impurity for patients partaking in it. Additionally, strong regulatory guidelines propel the segment hold
- By scale of operations, the manufacturing segment captured the largest share of 64.95% in 2022. The dominant share is due to an immense scale of drug manufacturing and various process control in place to ensure safety, thereby, increasing the usage of pharmaceutical filtration products at the manufacturing scale
- North America holds a key position in the pharmaceutical filtration industry with a share of 43.23% in 2022. It can be attributed to the presence of various large-scale manufacturers in the region along with a strong healthcare infrastructure, supporting both the development and consumption of biopharmaceuticals
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 150 |
| Forecast Period | 2022 – 2030 |
| Estimated Market Value (USD) in 2022 | $11.67 Billion |
| Forecasted Market Value (USD) by 2030 | $21.96 Billion |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Pharmaceutical Filtration Market Variables And Trends
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Impact Analysis
3.2.1.1. Growing Biopharmaceutical Industry
3.2.1.2. Rising R&D Expenditure By Biopharmaceutical Firms
3.2.1.3. Growing Adoption Of Single-Use Technologies
3.2.1.4. Growing Purity Requirements In End-User Use.
3.2.2. Market Restraint Impact Analysis
3.2.2.1. Membrane Fouling Issue.
3.3. Impact Of The Covid-19 Pandemic
3.4. Industry Analysis Tools
Chapter 4. Pharmaceutical Filtration Market: Product Estimates & Trend Analysis
Chapter 5. Pharmaceutical Filtration Market: Technique Estimates & Trend Analysis
Chapter 6. Pharmaceutical Filtration Market: Type Estimates & Trend Analysis
Chapter 7. Pharmaceutical Filtration Market: Application Estimates & Trend Analysis
Chapter 8. Pharmaceutical Filtration Market: Scale Of Operation Estimates & Trend Analysis
Chapter 9. Pharmaceutical Filtration Market: Regional Estimates And Trend Analysis
Chapter 10. Pharmaceutical Filtration Market: Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/r/93cspq
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900